The Methods for Improving Reproductive Health in Africa (MIRA) trial found no statistical difference in the rate of new HIV infections between women who received the diaphragm plus lubricant along with male condoms for their partners and those in the control arm who only received male condoms. Therefore, the results do not support the addition of the diaphragm to current HIV prevention strategies. To date, condoms remain the only proven barrier method for HIV prevention. This means there is still an urgent need for continued investment and research into current and new HIV prevention methods that give women and girls the power to protect their health.
Resources on the MIRA Trial Results:
- Article from the journal, The Lancet (Free registration required to access article.)
- Questions & Answers: The MIRA Diaphragm Trial Results
- MIRA Key Findings and Publications
- MIRA Fact Sheet and Timeline
- Press release from the University of California, San Francisco
- Female-Initiated HIV Prevention: What will we learn from upcoming trials? by the AIDS Vaccine Advocacy Coalition in collaboration with the African Microbicides Advocacy Group and the Global Campaign for Microbicides
See additional coverage of the results:
- San Francisco Chronicle
- Wall Street Journal (Available to subscribers only.)
- DG News
- Indian Muslims
- Medpage Today
- The Money Times India
If you have any difficulty accessing any of these materials, please email firstname.lastname@example.org.